Bing

Oct. 4, 2010 -- A new vaccine for a deadly brain cancer known as glioblastoma doubled the survival time of patients, researchers from Duke University report. The new vaccine, he says, "seems to be twice as good as the standard therapy alone." The results ...
WebMD · ByKathleen Doheny · 10/4/2010
A vaccine aimed against an aggressive form of brain cancer showed promise in an early-stage clinical trial, extending life expectancy by nearly 50 percent, according to research presented Tuesday. The customized vaccine uses the patient's own tumor cells ...
International Business Times · 4/18/2012
Researchers who have harnessed the body's immune system to fight cancer have found a way to make the approach work even better, using an ordinary tetanus vaccine. They used their double-vaccine approach to greatly lengthen the lives of patients with …
KGW 8 Portland · 3/11/2015
A new treatment for glioblastoma - an aggressive type of brain cancer that claimed the life of Sen. Ted Kennedy last year - is helping extend lives, CNN's Dr. Sanjay Gupta, a neurosurgeon and CBS News contributing ... working on a vaccine that could ...
CBS News · 10/4/2010
“This is a proof-of-principle study,” said Darell Bigner, a cancer researcher and brain tumor expert at Duke University in North Carolina. “The tumor-specific peptides [used in this study] have potential as a tumor vaccine, and should be evaluated in ...
The Scientist · 6/25/2014
Glioblastoma is the most common and aggressive brain cancer in humans ... Yeah it has because I think it's going to work." Parsa hopes the vaccine will help change glioblastoma from a terminal cancer, to a chronic condition like diabetes that can be ...
ABC 30 News · 11/15/2014
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent ...
UC San Fransisco · 4/17/2012
Glioblastomas are the most deadly types of brain tumors. Even with current treatments like chemo and radiation, most patients live less than two years. Now, a new vaccine is giving some the gift of time. Michael Wulfe shouldn't even be alive -- much less ...
Ivanhoe · 2/18/2011
Researchers at Thomas Jefferson University have been working on a cancer vaccine that would extend that survival by activating the patient’s immune system to fight the brain tumor. A study published online November 13th in the journal Cancer
News Wise · 11/13/2014
TUESDAY, April 17 (HealthDay News) -- A vaccine made from brain cancer patients' own tumor cells led to a nearly 50 percent improvement in survival times for those stricken with glioblastoma multiforme, the same malignancy that claimed the life of U.S. Sen.
Medicine Net · 4/20/2014